Please use this identifier to cite or link to this item: https://doi.org/10.1007/s10549-007-9711-8
DC FieldValue
dc.titleAnti-estrogenic mechanism of unliganded progesterone receptor isoform B in breast cancer cells
dc.contributor.authorZheng, Z.-Y.
dc.contributor.authorZheng, S.-M.
dc.contributor.authorBay, B.-H.
dc.contributor.authorAw, S.-E.
dc.contributor.authorLin, V.C.-L.
dc.date.accessioned2015-09-07T09:55:31Z
dc.date.available2015-09-07T09:55:31Z
dc.date.issued2008-07
dc.identifier.citationZheng, Z.-Y., Zheng, S.-M., Bay, B.-H., Aw, S.-E., Lin, V.C.-L. (2008-07). Anti-estrogenic mechanism of unliganded progesterone receptor isoform B in breast cancer cells. Breast Cancer Research and Treatment 110 (1) : 111-125. ScholarBank@NUS Repository. https://doi.org/10.1007/s10549-007-9711-8
dc.identifier.issn01676806
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/120674
dc.description.abstractOver half of breast cancer cases are estrogen-dependent and strategies to combat estrogen-dependent breast cancer have been to either block the activation of estrogen receptor (ER) or diminish the supply of estrogens. Our previous work documented that estrogen-independent expression of progesterone receptor (PR) in MCF-7 cells markedly disrupted the effects of estrogen. In this study, we have developed an adenovirus-mediated gene delivery system to study the specific involvement of PR isoform A (PR-A) and PR-B in the anti-estrogenic effect and its mechanism of action. The results revealed that PR-B, but not PR-A, exhibited distinct anti-estrogenic effect on E2-induced cell growth, gene expression, and ER-ERE interaction in a ligand-independent manner. The anti-estrogenic effect of PR-B was also associated with heightened metabolism and increased cellular uptake of estradiol-17β (E2). We have also found that the B-upstream segment of PR-B alone was able to inhibit E2-induced ER-ERE interaction and cellular uptake of E2. Although PR-A alone did not affect E2-induced ER activity, it antagonized the anti-estrogenic effect of PR-B in a concentration-dependent manner. The findings suggest an important mechanism of maintaining a favorable level of ER activity by PR-A and PR-B in estrogen target cells for optimal growth and differentiation. The potential anti-estrogenic mechanism of PR-B may be exploited for breast cancer therapy. © 2007 Springer Science+Business Media, LLC.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1007/s10549-007-9711-8
dc.sourceScopus
dc.subjectAdenovirus-mediated gene delivery
dc.subjectB-upstream segment
dc.subjectBreast cancer
dc.subjectEstrogen receptor
dc.subjectProgesterone receptor
dc.typeArticle
dc.contributor.departmentANATOMY
dc.description.doi10.1007/s10549-007-9711-8
dc.description.sourcetitleBreast Cancer Research and Treatment
dc.description.volume110
dc.description.issue1
dc.description.page111-125
dc.description.codenBCTRD
dc.identifier.isiut000256471000010
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

12
checked on Nov 30, 2022

WEB OF SCIENCETM
Citations

11
checked on Nov 30, 2022

Page view(s)

157
checked on Nov 24, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.